Abstract:Importance Cognitive impairment contributes significantly to clinical outcome and level of function in individuals with psychotic disorders. These impairments are present already at psychosis onset at a group level; however, the question of heterogeneity in cognitive function among patients has not been systematically investigated. Objective To provide an updated quantification of cognitive impairment at psychosis onset before patients receive potentially confounding antipsychotic treatment, and to investigate variability in cognitive function compared with healthy controls. Data Sources In this systematic review and meta-analysis, PubMed articles were searched up to September 15, 2022. Study Selection Original studies reporting data on cognitive function in antipsychotic drug–naive patients with first-episode psychosis (FEP) were included. Data Extraction and Synthesis Data were independently extracted by 2 researchers. Cognitive tasks were clustered according to 6 domains of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery and the domain of executive function. Random-effects model meta-analyses of mean differences and coefficient of variation ratios (CVRs) were performed, as well as meta-regressions, assessment of study quality, and publication bias. Main Outcomes and Measures The main outcome measure was Hedges g for mean differences in cognition and CVR for within-group variability. Results Fifty studies were included in the analysis with a total of 2625 individuals with FEP (mean [SD] age, 25.2 [3.6] years, 60% male; 40% female) and 2917 healthy controls (mean [SD] age, 26.0 [4.6]; 55% male; 45% female). In all cognitive domains, the FEP group displayed significant impairment compared with controls (speed of processing: Hedges g = −1.16; 95% CI, −1.35 to −0.98; verbal learning: Hedges g = −1.08; 95% CI, −1.28 to −0.88; visual learning: Hedges g = −1.05; 95% CI, −1.27 to −0.82; working memory: Hedges g = −1.04; 95% CI, −1.35 to −0.73; attention: Hedges g = −1.03; 95% CI, −1.24 to −0.82; reasoning/problem solving: Hedges g = −0.90; 95% CI, −1.12 to −0.68; executive function: Hedges g = −0.88; 95% CI, −1.07 to −0.69). Individuals with FEP also exhibited a larger variability across all domains (CVR range, 1.34-1.92). Conclusions and Relevance Results of this systematic review and meta-analysis identified cognitive impairment in FEP before the initiation of antipsychotic treatment, with large effect sizes. The high variability within the FEP group suggests the need to identify those individuals with more severe cognitive problems who risk worse outcomes and could benefit the most from cognitive remediation.

A Comparison of Neuropsychological Dysfunction in First-Episode Psychosis Patients with Unipolar Depression, Bipolar Disorder, and Schizophrenia.

Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.

The Comparison of Impairment of Cognitive Function in First-Episode Schizophrenia, Bipolar Disorder and Major Depressive Disorder

Comparison of cognitive performance in first-episode drug-naïve schizophrenia, bipolar II disorder, and major depressive disorder patients after treatment

Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode

The neurocognitive function in patients with first-episode schizophrenia treated in early stage

Disease and Drug Effects on Internally-Generated and Externally-Elicited Responses in First Episode Schizophrenia and Psychotic Bipolar Disorder

Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing Rbans Performance

Pretreatment and Longitudinal Studies of Neuropsychological Deficits in Antipsychotic-Naïve Patients with Schizophrenia.

The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies

Cognitive Function in First-Episode Adolescent-Onset Schizophrenia Before and after Treatment

Assessment of Cognitive Functions Among Remitted Patients of Schizophrenia and Bipolar Disorder: A Comparative Study

Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia

Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives

Neuropsychological Performance in Bipolar I, Bipolar II and Unipolar Depression Patients: a Longitudinal, Naturalistic Study.

Response Suppression Deficits in Treatment-Naïve First-Episode Patients with Schizophrenia, Psychotic Bipolar Disorder and Psychotic Major Depression

Eff Ectiveness of Antipsychotic Drugs in Fi Rst-Episode Schizophrenia and Schizophreniform Disorder : an Open Randomised Clinical Trial

Examination and Comparison of Cognitive and Executive Functions in Clinically Stable Schizophrenia Disorder, Bipolar Disorder, and Major Depressive Disorder

Cognitive Function and Variability in Antipsychotic Drug–Naive Patients With First-Episode Psychosis

A Comparision of Neurocognitive Function among Patients with Bipolar Depression, Recurrent Unipolar Depression and Schizophrenia

The comparative study of cognitive functions between familial and sporadic patients with first-episode schizophrenia